ZOSTAVAX II
ZOSTAVAX II
Discontinued
DIN Number
02375516
Drug Class
Human
Market Date
May 26, 2014
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02375516
AIG Number0152480003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BK02 ZOSTER, LIVE ATTENUATED
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN)Active
Strength: 19400 PFU / 0.65 ML
Monograph: VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN)